Pharmafile Logo
Pharmafocus logo
Advanced Search

‘Ticking time bomb’ will go off as NHS investment slows

July 6, 2005

News

Lilly buys rights to novel diabetes drug

July 6, 2005
Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …

News

Orphans join European pharma family

July 5, 2005
Sales and Marketing

Feature

Antidepressants come under FDA review again

July 4, 2005
Sales and Marketing

The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …

News

GSK excited about new vaccines

July 4, 2005
Sales and Marketing

GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …

News

Doctors have no time to mentor nurse prescribers

June 30, 2005

Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …

News

NHS to save

June 30, 2005

News

Bright future for new antidepressants

June 30, 2005
Research and Development, Sales and Marketing

News

The golden rules of PR

June 29, 2005
Medical Communications

In light of the enormous potential brand benefits of pharma PR,  the question should not be 'Shall we invest in …

Feature

Humira receives two European recommendations

June 29, 2005
Sales and Marketing

Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …

News

All aboard the health train

June 29, 2005
Medical Communications

Making friends and influencing people is an area, it's widely agreed, where big pharma could do better. Few companies, however, …

Feature

New products key to Schering growth

June 29, 2005
Sales and Marketing

Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …

News

FDA approves new HIV drug Aptivus

June 29, 2005
Sales and Marketing

Boehringer Ingelheim's new HIV drug Aptivus has been granted accelerated approval by the FDA. Aptivus (tipranavir) has been approved for …

News

GSK forms hypertension alliance

June 29, 2005
Sales and Marketing

GlaxoSmithKline has formed a strategic alliance with an emerging pharma company to develop and commercialise novel compounds to treat hypertension …

News

FDA approves first ‘ethnic’ heart drug

June 29, 2005
Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …

News

Woolley Pau wins Chiron campaign

June 29, 2005
Medical Communications

Woolley Pau has been appointed by Chiron Biopharma Europe to work on a pan-European launch campaign, following a four-way pitch.A …

News

People Strategies launch

June 28, 2005
Sales and Marketing

A new company has been launched to bring people and change management expertise to companies that are not able to …

News

Seven Stones expands into market research with Strata

June 28, 2005
Medical Communications

Healthcare communications agency Seven Stones has launched a new market research company to be run by a former head of …

News

Public involvement part of Labour’s vision for primary care

June 28, 2005

Health secretary Patricia Hewitt has announced plans for a major public engagement exercise to help make far-reaching changes to primary …

News

NHS chief executives call for an extension of patient choice

June 28, 2005

An overwhelming majority of NHS chief executives believe patient choice should be extended to treatment as well as service providers, …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026